Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Patil

Showing results (61-70 of 189) with videos related to

Pageof 19
Sort By:
Indian Journal of Surgical Oncology|April 25, 2022
Systemic Therapy in Thyroid CancerAmit Kumar Agrawal, Vanita Noronha, Vijay Patil, et al.
Ecancermedicalscience|September 8, 2022
Leptomeningeal metastasis from non-small cell lung cancer- a <i>post-hoc</i> analysis from four randomised clinical trialsVijay Patil, Vanita Noronha, Dilip Harindran Vallathol, et al.
Ecancermedicalscience|November 29, 2018
Thromboembolic events in patients with advanced stage non-small cell lung cancer treated with platinum-based chemotherapy: a prospective observational studyAmit Joshi, Shruti Kate, Vanita Noronha, et al.
Indian Journal of Surgical Oncology|December 7, 2020
Robotic Complete Mesocolic Excision with Central Vascular Ligation for Right Colon Cancer: Surgical Technique and Short-term OutcomesC Ramachandra, Pavan Sugoor, Uday Karjol, et al.
The Lancet Regional Health. Southeast Asia|June 29, 2023
Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancerSachin Babanrao Dhumal, Vijay Patil, Deevyashali Parekh, et al.
Therapeutic Advances in Drug Safety|February 25, 2021
Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapyJyoti Bhagatram Sharma, Manjunath Nookala Krishnamurthy, Ankita Awase, et al.
International Journal of Surgical Pathology|May 28, 2020
Melanotic Schwannoma, a Deceptive Misnomer for a Tumor With Relative Aggressive Behavior: A Series of 7 Cranial and Spinal CasesAyushi Sahay, Sridhar Epari, Priyanka Gupta, et al.
Indian Journal of Surgical Oncology|February 5, 2026
PD-L1 in Oral Cavity Cancers-Audit for Tertiary Care Center in IndiaZoya Peelay, Vijay Patil, Neha Mittal, et al.
Exploration of Targeted Anti-Tumor Therapy|November 16, 2023
Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancerAbhishek Mahajan, Devendra Goyal, Ujjwal Agarwal, et al.
Ecancermedicalscience|February 23, 2023
Retrospective analysis: checkpoint inhibitor accessibility for thoracic and head and neck cancers and factors influencing it in a tertiary centre in IndiaVijay Patil, George Abraham, Madala Ravikrishna, et al.
Pageof 19

Showing results (61-70 of 189) with videos related to

Sort By:
Pageof 19
Indian Journal of Surgical Oncology|April 25, 2022
Systemic Therapy in Thyroid CancerAmit Kumar Agrawal, Vanita Noronha, Vijay Patil, et al.
Ecancermedicalscience|September 8, 2022
Leptomeningeal metastasis from non-small cell lung cancer- a <i>post-hoc</i> analysis from four randomised clinical trialsVijay Patil, Vanita Noronha, Dilip Harindran Vallathol, et al.
Ecancermedicalscience|November 29, 2018
Thromboembolic events in patients with advanced stage non-small cell lung cancer treated with platinum-based chemotherapy: a prospective observational studyAmit Joshi, Shruti Kate, Vanita Noronha, et al.
Indian Journal of Surgical Oncology|December 7, 2020
Robotic Complete Mesocolic Excision with Central Vascular Ligation for Right Colon Cancer: Surgical Technique and Short-term OutcomesC Ramachandra, Pavan Sugoor, Uday Karjol, et al.
The Lancet Regional Health. Southeast Asia|June 29, 2023
Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancerSachin Babanrao Dhumal, Vijay Patil, Deevyashali Parekh, et al.
Therapeutic Advances in Drug Safety|February 25, 2021
Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapyJyoti Bhagatram Sharma, Manjunath Nookala Krishnamurthy, Ankita Awase, et al.
International Journal of Surgical Pathology|May 28, 2020
Melanotic Schwannoma, a Deceptive Misnomer for a Tumor With Relative Aggressive Behavior: A Series of 7 Cranial and Spinal CasesAyushi Sahay, Sridhar Epari, Priyanka Gupta, et al.
Indian Journal of Surgical Oncology|February 5, 2026
PD-L1 in Oral Cavity Cancers-Audit for Tertiary Care Center in IndiaZoya Peelay, Vijay Patil, Neha Mittal, et al.
Exploration of Targeted Anti-Tumor Therapy|November 16, 2023
Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancerAbhishek Mahajan, Devendra Goyal, Ujjwal Agarwal, et al.
Ecancermedicalscience|February 23, 2023
Retrospective analysis: checkpoint inhibitor accessibility for thoracic and head and neck cancers and factors influencing it in a tertiary centre in IndiaVijay Patil, George Abraham, Madala Ravikrishna, et al.
Pageof 19